APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation

Jessica A. Occhiuto, Silpa Gampala, Melissa L. Fishel, Mark R. Kelley

Open source

DOI
10.1080/14728222.2026.2706465
Published
2026-07-03
Container
Expert Opinion on Therapeutic Targets
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14728222.2026.2706465,
  title = {APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation},
  author = {Jessica A. Occhiuto and Silpa Gampala and Melissa L. Fishel and Mark R. Kelley},
  year = {2026},
  journal = {Expert Opinion on Therapeutic Targets},
  doi = {10.1080/14728222.2026.2706465},
  url = {https://doi.org/10.1080/14728222.2026.2706465}
}

RIS

TY  - JOUR
TI  - APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation
AU  - Jessica A. Occhiuto
AU  - Silpa Gampala
AU  - Melissa L. Fishel
AU  - Mark R. Kelley
PY  - 2026
JO  - Expert Opinion on Therapeutic Targets
DO  - 10.1080/14728222.2026.2706465
UR  - https://doi.org/10.1080/14728222.2026.2706465
ER  - 

APA

Occhiuto, J. A., Gampala, S., Fishel, M. L., & Kelley, M. R. (2026). APE1/Ref-1: multifunctional biology, selective inhibition, and the path to clinical translation. Expert Opinion on Therapeutic Targets. https://doi.org/10.1080/14728222.2026.2706465

Source records